Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Standard therapy for Pediatric Rhabdomyosarcoma and Ewing Sarcoma family of tumors.
Low-risk pediatric Hodgkin Lymphoma and Acute Lymphoblastic Leukemia consolidation.
Advanced Germ Cell Tumors and Refractory Small Cell Lung Cancer.
Approved for use in oncology care according to FDA-approved indications.
Approved for use in oncology care according to FDA-approved indications.
Approved for use in oncology care according to FDA-approved indications.
Advanced solid tumors and hematologic malignancies with matching genomic alterations.
Prevention and management of chemotherapy-induced and radiation-induced nausea and vomiting (CINV).
Salvage therapy for relapsed or refractory Germ Cell Tumors (testicular cancer).
KRAS wild-type Metastatic Colorectal Cancer, Squamous Cell Carcinoma of the Head and Neck, and Non-Small Cell Lung Cancer.
Multiple Myeloma and Myelodysplastic Syndromes.
BRAF V600E/K mutation-positive Melanoma, Non-Small Cell Lung Cancer, Anaplastic Thyroid Cancer, and Colorectal Cancer.
